DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
04/27/2023* 08:30 EST Earnings Call Q1 2023 -- -- --
04/27/2023* -- Results Q1 2023 -- -- --
02/23/2023 08:30 EST Earnings Call Q4 2022 -- -- --
02/23/2023 -- Results Q4 2022 -0.06 -0.16 63.55%
11/08/2022 08:30 EST Earnings Call Q3 2022 -- -- --
11/08/2022 -- Results Q3 2022 -0.14 -0.21 32.09%
08/09/2022 08:30 EST Earnings Call Q2 2022 -- -- --
08/09/2022 -- Results Q2 2022 -0.16 -0.23 29.01%
*Estimated Date/Time

Earnings

Next Report Date 04/27/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 02/23/2023
Beat/Miss Upgrade
Return Since 1.44%
Last FQE 12/31/2022
Next FQE 03/31/2023

Profile

Edit
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
URL https://www.neogenomics.com
Investor Relations URL https://ir.neogenomics.com/
HQ State/Province Florida
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Apr. 27, 2023 (est.)
Last Earnings Release Feb. 23, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
8.89%
3.38%
42.33%
132.0%
84.07%
-36.63%
-72.92%
82.58%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
3.86%
-37.24%
25.27%
22.81%
139.3%
158.2%
-31.91%
-10.36%
-73.86%
--
--
--
--
-7.30%
-46.37%
-2.60%
27.81%
-75.14%
-42.53%
-65.00%
20.00%
-15.24%
-51.40%
-95.76%
-82.61%
--
29.73%
98.09%
264.4%
-39.53%
-78.67%
44.07%
125.6%
As of March 24, 2023.

Profile

Edit
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
URL https://www.neogenomics.com
Investor Relations URL https://ir.neogenomics.com/
HQ State/Province Florida
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Apr. 27, 2023 (est.)
Last Earnings Release Feb. 23, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
PDFDX 203280.0 USD 2.63%
PSCH 6.764M USD 2.37%
BSVSX 1.354M USD 2.34%
XHS 1.968M USD 1.90%
SKSZX 5.150M USD 1.88%
BIAYX 806643.0 USD 1.65%
BASAX 34.34M USD 1.63%
PNASX 22.08M USD 0.94%
EKG 7700.00 USD 0.93%
EWSC 131805.0 USD 0.27%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter NEO Tweets